skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi
I am down quite a bit on SNN? I am temped to sell for a tax loss and replace with xlv or IHI but am concerned that xlv or ihi as etfs do not have the same bounce potential as snn. is there another healthcare stock you can recommend or would you replace with xlv or ihi?
thanks
Read Answer Asked by Mary on December 09, 2022
Q: Question about Veeva Systems.

From prior responses, it aligned with right now having a high valuation even after the past years negative performance. Is this a good entry point? This has been on my watchlist for years now and each time I look at it, the valuation is too expensive. But with the recent drop is this a good entry point or do you think the market is signalling that growth is slowing down?
Read Answer Asked by Eugene on December 07, 2022
Q: I bought some medical start-ups in private placements around 2004 through 2007, including TMD Titan Medical. I bought into the both the Canadian and the US private placements. TMD has had a number of frustrating round-trips. Yesterday December 5, TMD stock saw considerable action both sides of border: opened yesterday at 0.90 Canadian , went up 40% to 1.25 closing the day at C$1.15 on high volume. Collapsed this morning. I see no news to explain the swing. The company sent shareholders anote about a strategic review. Perhaps a takeover is in the wings? Do you have any news on TMD? Would you hold or sell? (Tax loss not useable).
Read Answer Asked by Adam on December 06, 2022
Q: 1] Opsens Inc XTSE: OPS $2.23 CAD▲ +0.05 (+2.29%) today

2] OpSens Inc.

Short Description: Treasury Offering of Common Shares

Price: $1.90 CND per share.

Settlement: December 22, 2022.

Are 1 & 2 the same?

What does it do exactly? How do I buy it at $1.90? Is it worth buying?

Thank you.
Read Answer Asked by Ross on December 02, 2022
Q: Thanks for your useful answer. My info is that while legalization of pot in the US is not on the cards for the moment, a bill called the Safe Banking Act (in the US) is expected to pass in 2023 whose passage will allow institutional participation in the sector, which is something they cannot presently do, and a surge in purchases with significant associated price rises is anticipated as a result. This is some way out in front but the markets anticipate and I wondered how much of a hill Canopy for example had to climb, here or in the US.
Read Answer Asked by Mike on December 01, 2022
Q: Is there something to replace WELL in the Healthcare sector in Canada or US, ETF inclued?
Read Answer Asked by Yves on November 28, 2022
Q: Good Day All,

You recently answered a question on this company from another subscriber, and mentioned something about the cannabis sector. The way the answer was structured leaves me wondering about this remark as I don't believe CRRX operates in that sector; rather it provides drugs to seniors. Is the review of the fundamentals correct for the company, or are your comments based upon a different company in the cannabis sector? Could you clarify?
Read Answer Asked by Robert on November 25, 2022
Q: VRNA Your opinion of this co. as a new investment?
Read Answer Asked by Lesley on November 25, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!